The US has world-class scientific talent. The rest of the world is hoping to lure that away
As the Trump administration cut billions of dollars in federal funding to scientific research, thousands of scientists in the U.S. lost their jobs or grants — and governments and universities around the world spotted an opportunity.
The 'Canada Leads' program, launched in April, hopes to foster the next generation of innovators by bringing early-career biomedical researchers north of the border.
Aix-Marseille University in France started the 'Safe Place for Science' program in March — pledging to 'welcome' U.S.-based scientists who 'may feel threatened or hindered in their research.'
Australia's 'Global Talent Attraction Program,' announced in April, promises competitive salaries and relocation packages.
'In response to what is happening in the U.S.,' said Anna-Maria Arabia, head of the Australian Academy of Sciences, 'we see an unparalleled opportunity to attract some of the smartest minds here.'
Since World War II, the U.S. has invested huge amounts of money in scientific research conducted at independent universities and federal agencies. That funding helped the U.S. to become the world's leading scientific power — and has led to the invention of cell phones and the internet as well as new ways to treat cancer, heart disease and strokes, noted Holden Thorp, editor-in-chief of the journal Science.
But today that system is being shaken.
Since President Donald Trump took office in January, his administration has pointed to what it calls waste and inefficiency in federal science spending and made major cuts to staff levels and grant funding at the National Academy of Sciences, the National Institutes of Health, NASA and other agencies, as well as slashing research dollars that flow to some private universities.
The White House budget proposal for next year calls to cut the NIH budget by roughly 40% and the National Science Foundation's by 55%.
'The Trump administration is spending its first few months reviewing the previous administration's projects, identifying waste, and realigning our research spending to match the American people's priorities and continue our innovative dominance,' said White House spokesperson Kush Desai.
Already, several universities have announced hiring freezes, laid off staff or stopped admitting new graduate students. On Thursday, the Trump administration revoked Harvard University's ability to enroll international students, though a judge put that on hold.
Research institutions abroad are watching with concern for collaborations that depend on colleagues in the U.S. — but they also see opportunities to potentially poach talent.
'There are threats to science ... south of the border,' said Brad Wouters, of University Health Network, Canada's leading hospital and medical research center, which launched the 'Canada Leads' recruitment drive. 'There's a whole pool of talent, a whole cohort that is being affected by this moment.'
Promising a safe place to do science
Universities worldwide are always trying to recruit from one another, just as tech companies and businesses in other fields do. What's unusual about the current moment is that many global recruiters are targeting researchers by promising something that seems newly threatened: academic freedom.
European Commission President Ursula von der Leyen said this month that the European Union intends to 'to enshrine freedom of scientific research into law.' She spoke at the launch of the bloc's 'Choose Europe for Science' — which was in the works before the Trump administration cuts but has sought to capitalize on the moment.
Eric Berton, president of Aix-Marseille University, expressed a similar sentiment after launching the institution's 'Safe Place for Science' program.
'Our American research colleagues are not particularly interested by money,' he said of applicants. 'What they want above all is to be able to continue their research and that their academic freedom be preserved.'
Too early to say 'brain drain'
It's too early to say how many scientists will choose to leave the U.S. It will take months for universities to review applications and dole out funding, and longer for researchers to uproot their lives.
Plus, the American lead in funding research and development is enormous — and even significant cuts may leave crucial programs standing. The U.S. has been the world's leading funder of R&D — including government, university and private investment — for decades. In 2023, the country funded 29% of the world's R&D, according to the American Association for the Advancement of Science.
But some institutions abroad are reporting significant early interest from researchers in the U.S. Nearly half of the applications to 'Safe Place for Science' — 139 out of 300 total — came from U.S.-based scientists, including AI researchers and astrophysicists.
U.S.-based applicants in this year's recruitment round for France's Institute of Genetics, Molecular and Cellular Biology roughly doubled over last year.
At the Max Planck Society in Germany, the Lise Meitner Excellence Program — aimed at young female researchers — drew triple the number of applications from U.S.-based scientists this year as last year.
Recruiters who work with companies and nonprofits say they see a similar trend.
Natalie Derry, a U.K.-based managing partner of the Global Emerging Sciences Practice at recruiter WittKieffer, said her team has seen a 25% to 35% increase in applicants from the U.S. cold-calling about open positions. When they reach out to scientists currently based in the U.S., 'we are getting a much higher hit rate of people showing interest.'
Still, there are practical hurdles to overcome for would-be continent-hoppers, she said. That can include language hurdles, arranging childcare or eldercare, and significant differences in national pension or retirement programs.
Community ties
Brandon Coventry never thought he would consider a scientific career outside the United States. But federal funding cuts and questions over whether new grants will materialize have left him unsure. While reluctant to leave his family and friends, he's applied to faculty positions in Canada and France.
'I've never wanted to necessarily leave the United States, but this is a serious contender for me,' said Coventry, who is a postdoctoral fellow studying neural implants at the University of Wisconsin-Madison.
But it's not easy to pick up and move a scientific career — let alone a life.
Marianna Zhang was studying how children develop race and gender stereotypes as a postdoctoral fellow at New York University when her National Science Foundation grant was canceled. She said it felt like 'America as a country was no longer interested in studying questions like mine.'
Still, she wasn't sure of her next move. 'It's no easy solution, just fleeing and escaping to another country,' she said.
The recruitment programs range in ambition, from those trying to attract a dozen researchers to a single university to the continent-wide 'Choose Europe' initiative.
But it's unclear if the total amount of funding and new positions offered could match what's being shed in the U.S.
A global vacuum
Even as universities and institutes think about recruiting talent from the U.S., there's more apprehension than glee at the funding cuts.
'Science is a global endeavor,' said Patrick Cramer, head of the Max Planck Society, noting that datasets and discoveries are often shared among international collaborators.
One aim of recruitment drives is to 'to help prevent the loss of talent to the global scientific community,' he said.
Researchers worldwide will suffer if collaborations are shut down and databases taken offline, scientists say.
'The U.S. was always an example, in both science and education,' said Patrick Schultz, president of France's Institute of Genetics, Molecular and Cellular Biology. So the cuts and policies were 'very frightening also for us because it was an example for the whole world.'
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
14 minutes ago
- Medscape
GLP-1 Users Should Fast 24 Hours Before Anesthesia
Patients taking the new class of weight-loss drugs do not need to stop these medications prior to procedures requiring anesthesia, but they should adhere to longer preoperative fasting times, according to a new multidisciplinary consensus statement. The statement, led by the Society for Perioperative Assessment and Quality Improvement, recommends patients without significant gastrointestinal symptoms associated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) should fast from solid foods for 24 hours and stick to clear liquids prior to a procedure requiring anesthesia. This extended fasting time can help mitigate aspiration risk in these patients with delayed gastric emptying while retaining the benefits of continuing GLP-1 RAs, such as improved glycemic control. The statement is 'the first to provide recommendations for perioperative management of patients taking GLP-1 RAs based on an in-depth systematic literature review of both clinical perioperative studies and gastric emptying data,' Adriana Oprea, MD, the first author of the document, and her colleagues wrote. Changing Guidance In June 2023, the American Society of Anesthesiologists (ASA) released the first guidance statement regarding preoperative management of patients on GLP-1 RAs, after some case reports documented aspiration events in these patients. While the number of these events is generally low and rates of aspiration appear to be similar between patients on GLP-1 RAs and the general population, 'people got really worried with these drugs because of [the] delayed gastric emptying,' Oprea, an associate professor of anesthesiology at Yale School of Medicine in New Haven, Connecticut, told Medscape Medical News . The 2023 ASA guidance recommended holding GLP-1 RAs for one half-life — a week for patients on long-acting medication and a day for short-acting GLP-1s. Due to a lack of adequate evidence at the time, the document suggested these patients should follow the standard ASA fasting guidelines of 8 hours after a full meal. However, evidence suggests stopping GLP-1s for one half-life is not enough for the effects on gastric emptying to subside, according to the new statement. For longer-acting drugs like dulaglutide, semaglutide, and tirzepatide, patients would need to discontinue these medications for several weeks to restore normal gastrointestinal motility. For patients with type 2 diabetes, discontinuation of these medications over this period could lead to poor glycemic control, which is linked to worse postoperative outcomes. For patients taking GLP-1 RAs for weight loss, restarting these medications can result in increased gastrointestinal symptoms, Oprea said, such as nausea, vomiting, diarrhea, or constipation. 'Because adverse effects are more prevalent at higher GLP-1 RA doses, discontinuation of these medications might lead to a high likelihood of side effects upon medication reinitiation or require reinitiation of therapy at lower doses followed by dose reescalation,' Oprea's group wrote. 'This is logistically difficult for both patients and treating clinicians.' In October 2024, the ASA, along with other professional societies, published updated practice guidance stating GLP-1 RAs may be continued preoperatively in patients without an elevated risk for delayed gastric emptying and aspiration. Those defined as 'higher risk' included patients in the escalation phase, on weekly dosing, on higher doses, and with gastrointestinal symptoms. The guidance advised these patients at higher risk for delayed stomach emptying can help mitigate aspiration risk by following a 24-hour liquid diet. This updated guidance also received some criticism. 'As of yet, no studies have reported a difference in the incidence of increased residual gastric content that would justify treating patients differently on the basis of dose regimen and/or treatment phase,' wrote Glenio B. Mizubuti, MD, PhD, of the Kingston General Hospital, in Kingston, Ontario, Canada, and his colleagues in a letter to Anesthesiology . 'Similarly, the absence of ongoing digestive symptoms, while somewhat reassuring, should not be taken as a definitive sign of an empty stomach in GLP-1 RA users,' they wrote. Continue Meds, Extend Fasting Times This new consensus statement, published last month in the British Journal of Anaesthesia , recommends patients doing well on GLP-1 RAs should continue these medications preoperatively and follow a clear liquid diet for 24 hours before procedures requiring anesthesia. The recommendations were based on a systematic review of 112 studies and a modified Delphi process and were co-sponsored and endorsed by the American Association of Clinical Endocrinology. 'From our review of the literature, we feel that the fasting times are the most important factor that could decrease the risk of having residual gastric content in the stomach in a patient on GLP-1 RAs when they're scheduled to have a procedure that requires anesthesia,' Oprea said. The consensus also recommends patients on GLP-1s fast from high-carbohydrate-content clear liquids (containing 10% or more glucose) for 8 hours before and stop drinking any liquids four hours before these procedures. Inpatient and outpatients can restart GLP-1 RAs when they resume their original diets. Patients with significant gastrointestinal symptoms including severe nausea, vomiting, and inability to tolerate oral intake should postpone elective procedures that require anesthesia and refer to their prescribing physician for diet and medication modifications to manage symptoms, the authors advised. 'Our recommendation for a clear liquid diet for 24 hours preprocedurally might appear overly restrictive. However, evidence points to the safety of this approach in patients on GLP-1 RAs,' they wrote.


CNN
21 minutes ago
- CNN
President Trump signs new travel ban
President Trump signs new travel ban President Donald Trump announced a new travel ban, blocking several countries from entry to the US. The ban will fully restrict entry of nationals from Afghanistan, Myanmar, Chad, Republic of the Congo, Equatorial Guinea, Eritrea, Haiti, Iran, Libya, Somalia, Sudan and Yemen. It will also partially restrict nationals from Burundi, Cuba, Laos, Sierra Leone, Togo, Turkmenistan and Venezuela. The proclamation signed does include exceptions for lawful permanent residents, existing visa holders, certain visa categories and individuals whose entry serves US national interests.

Washington Post
23 minutes ago
- Washington Post
Another Oval Office showdown?
Good morning, Early Birds. Anyone else want to see the U.S. announce election results like they do in South Korea? Send tips to earlytips@ Thanks for waking up with us. In today's edition … We have a price tag for the House-passed GOP tax and spending bill … The secretaries of commerce and labor will face a grilling in Congress … but first …